Clinical benefit and incremental.

Strategy	Reduction in the risk of CC (%)^b	Cost per individual vaccinated
Strategy	Reduction in the risk of CC (%)^b	US$ 25	US$ 50	US$ 100	US$ 400
Coverage Girls only Both sexes	14 21	Superior^c 110	30 810	610 2.190	3450 9,370
Coverage Girls only Both sexes	29 40	Superior^c 660	70 1,740	540 3,900	3210 15,120
Coverage Girls only Both sexes	45 57	Superior^c 2,440	130 2,180	740 4,860	3,940 18,820
Coverage Girls only Both sexes	63 67	Superior^c 9,110	170 18,650	810 37,720	4,180 136,910

^aValues represent the additional cost divided by the clinical benefit in terms of years of life saved, compared to the base strategy of not vaccinating (US$/QALY)
^b Percent reduction in the risk of CC over a lifetime
^c Superior means that the vaccine strategy is more efficient and less costly than the alternative

Table 5: Clinical benefit and incremental cost-effectiveness ratio for vaccine coverage and for vaccination cost^a [27].

Goto home»